Michael Gelband’s Tyra Biosciences TYRA Stock Holding History

Michael Gelband’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Buy	41,026 +26,960	+192%	+$892K	0.01%	986
2026 Q1	$539K	Sell	14,066 -28,725	-67%	-$930K	﹤0.01%	1175
2025 Q4	$1.12M	Buy	+42,791	New	+$786K	0.01%	953
2025 Q3	–	Sell	-67,442	Closed	-$645K	–	2039
2025 Q2	$645K	Buy	67,442 +37,207	+123%	+$354K	0.01%	1079
2025 Q1	$281K	Buy	+30,235	New	+$391K	﹤0.01%	1244
2024 Q3	–	Sell	-170,717	Closed	-$2.73M	–	2113
2024 Q2	$2.73M	Sell	170,717 -101,433	-37%	-$1.75M	0.02%	668
2024 Q1	$4.46M	Buy	+272,150	New	+$4.46M	0.03%	430

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Michael Gelband's TYRA Position: Q2 2026 in Review

Michael Gelband increased its Tyra Biosciences (TYRA) stake by 192% in Q2 2026, buying an estimated $892K and bringing the position to 41,026 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #986.

Michael Gelband first reported a position in TYRA in Q1 2024 and has held it in 7 quarters since. The position peaked at $4.46M in Q1 2024. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

Michael Gelband held 41,026 shares of Tyra Biosciences worth $1.31M as of Q2 2026.
Michael Gelband bought 26,960 Tyra Biosciences shares in Q2 2026, an estimated $892K.
Tyra Biosciences made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #986 holding.
Michael Gelband first reported a position in Tyra Biosciences in Q1 2024 and has held it in 7 quarters since.
Michael Gelband's Tyra Biosciences position peaked at $4.46M in Q1 2024.
169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.